Home The Word Brain My Amedeo FAQ Privacy About   


Amedeo C49

English + 你好 (nǐ hǎo) = limitless possibilities.
Start learning Mandarin Chinese today—for free, forever.

Amedeo C49 is completely free, for life. Next week: +49.


  Nuclear Medicine

  Free Subscription


29.09.2025

2 AJNR Am J Neuroradiol
5 Ann Nucl Med
1 Brain
4 Clin Nucl Med
1 J Cereb Blood Flow Metab
3 J Nucl Cardiol
7 J Nucl Med
1 Neurology
1 Nucl Med Commun


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    AJNR Am J Neuroradiol

  1. MASHRIQI F, Chen M, Keir G, Caravella C, et al
    Hybrid [(18)F] Fluoroestradiol Brain PET/CT/MRI for Detection of Estrogen Receptor-Positive Intracranial Metastases Compared with MRI and Vertex-to-Below the Knees PET Imaging.
    AJNR Am J Neuroradiol. 2025 Sep 18. doi: 10.3174/ajnr.A8863.
    PubMed         Abstract available

  2. VIJAYASHANKAR A, Keir G, Sagnelli M, Petrover D, et al
    Added Value of Amyloid PET Quantification with the Centiloid Scale in Clinical Practice.
    AJNR Am J Neuroradiol. 2025 Sep 18. doi: 10.3174/ajnr.A8850.
    PubMed         Abstract available


    Ann Nucl Med

  3. LIU C, Song S
    Response to the comment on the impact of anti-HER2 therapy on the accuracy of 68 Ga-HER2-affibody PET/CT imaging in metastatic breast cancer.
    Ann Nucl Med. 2025 Sep 23. doi: 10.1007/s12149-025-02110.
    PubMed        

  4. LUE KH, Wang YH, Chen YH, Chu SC, et al
    The prognostic value of (18)F-FDG PET-derived whole-body feature in patients with lung adenocarcinoma treated with EGFR-targeted therapy.
    Ann Nucl Med. 2025 Sep 22. doi: 10.1007/s12149-025-02108.
    PubMed         Abstract available

  5. HOSOKAWA T, Uchiyama M, Namba S, Tanami Y, et al
    Association between technetium-99 m albumin scintigraphy-based severity of protein-losing enteropathy and patient characteristics and laboratory data.
    Ann Nucl Med. 2025 Sep 22. doi: 10.1007/s12149-025-02109.
    PubMed         Abstract available

  6. IMAI M, Ochiai Y, Kosaka Y, Mori K, et al
    Impact of body weight on arterial partition coefficient estimation in (123)I-IMP SPECT: a comparison between ARG and no-arterial sampling methods.
    Ann Nucl Med. 2025 Sep 19. doi: 10.1007/s12149-025-02104.
    PubMed         Abstract available

  7. RUZZEH S, Abdlkadir AS, Al-Alawi H, Lopci E, et al
    Evaluating the diagnostic utility of [(6)(8)Ga]Ga-Pentixafor in solid tumors: a systematic review.
    Ann Nucl Med. 2025;39:1053-1073.
    PubMed         Abstract available


    Brain

  8. JOHNSON DR, Wiste HJ, Lowe V, Schwarz CG, et al
    Staging Alzheimer's disease through amyloid and tau PET.
    Brain. 2025 Sep 19:awaf346. doi: 10.1093.
    PubMed         Abstract available


    Clin Nucl Med

  9. SANDLER I, Artoul F, Zick A, Ben-Shachar I, et al
    68Ga-FAPI-04 PET/CT Demonstrates Subtype-specific Uptake Patterns in Endometriosis With Added Diagnostic Value Beyond MRI.
    Clin Nucl Med. 2025 Sep 24. doi: 10.1097/RLU.0000000000006092.
    PubMed         Abstract available

  10. RUNGTA R, Venkatachalam M, Chowdhury Z, Suresh A, et al
    68Ga-FAPi PET-CT Demonstrating Diagnostic Superiority Over 18F-FDG PET-CT in Breast Carcinoma.
    Clin Nucl Med. 2025 Sep 19. doi: 10.1097/RLU.0000000000006141.
    PubMed         Abstract available

  11. SHANKARAMURTHY G, Gsb K, Ravindra BS, Kulkarni R, et al
    A Rare Case of Diffuse Neuroendocrine Tumor of the Pancreas Diagnosed by 68Ga-DOTANOC PET CT Study.
    Clin Nucl Med. 2025 Sep 19. doi: 10.1097/RLU.0000000000006140.
    PubMed         Abstract available

  12. KOORMA H, Jayanthi MR, Yalagudri S, Sekaran A, et al
    18F-FDG and 68Ga-FAPI PET/CT Imaging in a Rare Case of Lymphoma With Pericardial and Renal Involvement.
    Clin Nucl Med. 2025 Sep 19. doi: 10.1097/RLU.0000000000006122.
    PubMed         Abstract available


    J Cereb Blood Flow Metab

  13. HANANIA JU, Bevington CW, Cheng JK, Su D, et al
    A generalized framework for in vivo detection of dopamine release using positron emission tomography.
    J Cereb Blood Flow Metab. 2025 Sep 19:271678X251362958.
    PubMed         Abstract available


    J Nucl Cardiol

  14. DALEBOUT EM, Hirsch A, Mulders TA, Segbers M, et al
    Optimization of timing window and gating method for (18)F-FDG PET/CT in patients with suspected prosthetic valve endocarditis: A prospective pilot study.
    J Nucl Cardiol. 2025 Sep 20:102501. doi: 10.1016/j.nuclcard.2025.102501.
    PubMed        

  15. AJIMA T, Aikawa T, Saitou T, Matsue Y, et al
    Prognostic value of (99m)Tc-pyrophosphate uptake in patients with suspected transthyretin cardiac amyloidosis.
    J Nucl Cardiol. 2025;51:102452.
    PubMed         Abstract available

  16. BENZ DC, Flammer AJ, Schwotzer R, Buechel RR, et al
    How to perform and interpret cardiac amyloidosis radionuclide imaging (CARI).
    J Nucl Cardiol. 2025;51:102448.
    PubMed         Abstract available


    J Nucl Med

  17. VEIT-HAIBACH P
    Reply: Making Green Nuclear Medicine and Radiotheranostics Real in a Developing Country.
    J Nucl Med. 2025 Sep 18:jnumed.125.270767. doi: 10.2967/jnumed.125.270767.
    PubMed        

  18. DUAN X, Sarkar S, Lyo V, Romeo S, et al
    Quantification of (18)F-FDG Delivery Rate for Liver Inflammation Using Shortened Dynamic PET Imaging Protocols.
    J Nucl Med. 2025 Sep 18:jnumed.124.269434. doi: 10.2967/jnumed.124.269434.
    PubMed         Abstract available

  19. MALDONADO SP, Pedraza CM, Forero PA, Yepes MM, et al
    Making Green Nuclear Medicine and Radiotheranostics Real in a Developing Country.
    J Nucl Med. 2025 Sep 18:jnumed.125.270499. doi: 10.2967/jnumed.125.270499.
    PubMed        

  20. SHIYAM SUNDAR LK, Gutschmayer S, Pires M, Ferrara D, et al
    Fully Automated Image-Based Multiplexing of Serial PET/CT Imaging for Facilitating Comprehensive Disease Phenotyping.
    J Nucl Med. 2025 Sep 18:jnumed.125.269688. doi: 10.2967/jnumed.125.269688.
    PubMed         Abstract available

  21. WEIBERG D, Wilhelm LM, Felgenhauer T, Ross T, et al
    (68)Ga-FAPI-46 PET/CT in Primary Sclerosing Cholangitis and Suspected Cholangiocarcinoma.
    J Nucl Med. 2025 Sep 18:jnumed.125.270434. doi: 10.2967/jnumed.125.270434.
    PubMed         Abstract available

  22. DIEKMANN J, Konig T, Hess A, Zwadlo C, et al
    CXCR4 PET/CT Predicts Left Ventricular Recovery 8 Months After Acute Myocardial Infarction.
    J Nucl Med. 2025 Sep 18:jnumed.125.270807. doi: 10.2967/jnumed.125.270807.
    PubMed         Abstract available

  23. PACKARD RRS, Maddahi J, Pelletier-Galarneau M, Al-Mallah MH, et al
    SNMMI/EANM/ASNC/ACNM Procedure Standard/Practice Guideline for (18)F-Flurpiridaz PET Myocardial Perfusion Imaging and Blood Flow Quantitation.
    J Nucl Med. 2025 Sep 18:jnumed.125.270873. doi: 10.2967/jnumed.125.270873.
    PubMed        


    Neurology

  24. TRUDEL L, Therriault J, Macedo AC, Servaes S, et al
    Implication for Clinical Trials From Longitudinal Tau-PET Accumulation Across Biological Alzheimer Disease Stages.
    Neurology. 2025;105:e214111.
    PubMed         Abstract available


    Nucl Med Commun

  25. CHAUDHARY J, Kumar S, Sharma PD, Haresh KP, et al
    An assessment of conformance to structured reporting framework in 68Ga prostate-specific membrane antigen PET/computed tomography for prostate cancer staging.
    Nucl Med Commun. 2025 Sep 19. doi: 10.1097/MNM.0000000000002048.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Nuclear Medicine is free of charge.